U.S. scientists will conduct a year-long clinical trial to test the effectiveness of a stem cell treatment for patients with either ischemic or non-ischemic heart disease. They plan to develop cardiac-repair cells derived from the patients' bone marrow and inject these into their hearts to help boost muscle function and blood flow. The technique removes "the concern of rejection and the need for potentially harmful immunosuppressive drugs," a researcher said.

Related Summaries